Elicio Therapeutics (9HA.F) Q3 2025 Earnings

7AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-1.32
-1.07
-0.82
-0.57

Details

Expected EPS
-0.5865792000000001
Actual EPS
-0.5651712
Surprise EPS
0.02
Surprise Percent
+3.65%

Description

Elicio Therapeutics (9HA.F) has reported earnings of -0.5651712 per share for Q3 2025.

0 Comments

Share your thoughts